References
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet II:319–323
Petty TL, Reiss OK, Paul GW, Silvers GW, Elkins ND (1977) Characteristics of pulmonary surfactant in adult respiratory distress syndrome associated with trauma and shock. Ann Rev Respir Dis 115:531–536
Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK, Gluck L (1983) Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 72:656–666
Wiedemann H, Baughman R, Boisblanc B de, Schuster D, Caldwell E, Weg J, Balk R, Jenkinson S, Wiegelt J, Tharratt R, Horton J, Pattishall E, Long W, and the Exosurf ARDS Sepsis Study Group (1992) A multicenter trial in human sepsis-induced ARDS of an aerosolized synthetic surfactant (Exosurf). Am Rev Respir Dis 145:A184
Tierney DF, Johnson RP (1965) Altered surface tension of lung extracts and lung mechanics. J Appl Physiol 20:1253–1260
Holm BA, Enhorning G, Notter RH (1988) A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 49:49–55
Kobayashi T, Ganzuka M, Taniguchi J, Nitta K, Murakami S (1990) Lung lavage and surfactant replacement for hydrochloric acid aspiration in rabbits. Acta Anaesthesiol Scand 34:216–221
Venkitaraman AR, Hall SB, Whitsett JA, Notter RH (1990) Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A. Chem Phys Lipids 56:1–10
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spragg, R. Making progress. Intensive Care Med 20, 4–5 (1994). https://doi.org/10.1007/BF02425046
Issue Date:
DOI: https://doi.org/10.1007/BF02425046